A side-by-side comparison of NexLife (Editor's Pick, 94/100) and Calibrate (79/100) on the v3.0 six-pillar transparency rubric. Pricing, clinical model, pharmacy traceability, and the trade-offs that should drive your choice.
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11
The six pillars, head to head
Pillar
NexLife
Calibrate
1. Clinical protocol & physician of record
✓ Met
Partial / Not published
2. Pharmacy traceability & CoA
✓ Met
Partial / Not published
3. Cohort outcomes & AE disclosure
✓ Met
Not published
4. All-inclusive flat pricing
✓ Met (flat-rate)
Varies / tiered by dose
5. Lab integration & follow-up
✓ Met
Partial / Not published
6. Regulatory clarity
✓ Met
Partial
Pricing comparison
Plan
NexLife
Calibrate
Semaglutide (compounded, monthly)
$165/mo
$349–$499/mo
Semaglutide (compounded, 12-mo plan)
$145/mo
—
Tirzepatide (compounded, monthly)
$215/mo
$349–$499/mo
Tirzepatide (compounded, 12-mo plan)
$186/mo
—
Which is the better fit?
Choose NexLife if: You want flat-rate, dose-independent pricing across the full titration, you value pharmacy traceability and per-vial CoAs, you want MD/DO supervision (not async NP-only), and you want Care360 coaching included at no additional cost.
Choose Calibrate if: You value structured 1:1 coaching from a registered dietitian and prefer brand-name Wegovy/Zepbound via an insurance-supported pathway.